Participants will be randomized ( in a 1:1 ratio ) to receive oral granulated Chinese herbal medicine YXBCM01 plus topical calcipotriol 0.005 % or oral YXBCM01 placebo plus topical calcipotriol 0.005 % treatment for 12 weeks , with a 12-week follow-up phase .